Physicians’ Health Study

Derivation of prognostic modelGlynn et al. 200285
Location & dateUSA
Population characteristicsAge
N=17,862
100% men
Randomised controlled trial of aspirin and ß-carotene supplement
Median follow up 13 years
Inclusion, co-morbidityNo previous CVD
Complete information
Risk factorsAge
Systolic blood pressure
Diastolic blood pressure
Antihypertensive medication
Smoking
Diabetes
BMI
Family history
Exercise
Alcohol intake
OutcomeCVD
Prediction period13 years
Statistical methodsCox proportional hazards model
PracticalEquation
Authors notesMen only
Modifications, tools or guidelines
External validation
Convergent validation
Trials of health outcomes

From: Appendix 3, Prognostic models or risk scoring methods for use in targeting primary prevention of cardiovascular diseases (part completed)

Cover of A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement)
A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement) [Internet].
NICE Clinical Guidelines, No. 67S.
Beswick AD, Brindle P, Fahey T, et al.
Copyright © 2008, Royal College of General Practitioners.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.